U.S. Markets open in 8 hrs 19 mins

Eidos Therapeutics, Inc. (EIDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
92.64+2.93 (+3.27%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) -0.26
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 396.13
52 Week Low 328.39
50-Day Moving Average 377.84
200-Day Moving Average 355.45

Share Statistics

Avg Vol (3 month) 3224.49k
Avg Vol (10 day) 3168.11k
Shares Outstanding 538.59M
Float 13.29M
% Held by Insiders 165.61%
% Held by Institutions 131.19%
Shares Short (Nov 12, 2020) 4652.65k
Short Ratio (Nov 12, 2020) 43.46
Short % of Float (Nov 12, 2020) 45.88%
Short % of Shares Outstanding (Nov 12, 2020) 41.69%
Shares Short (prior month Oct 14, 2020) 4809.43k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)-77,050.39%

Management Effectiveness

Return on Assets (ttm)-35.95%
Return on Equity (ttm)-70.31%

Income Statement

Revenue (ttm)127k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-99.50%
Gross Profit (ttm)24.19M
EBITDA -97.57M
Net Income Avi to Common (ttm)-100.83M
Diluted EPS (ttm)-2.65
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)147.33M
Total Cash Per Share (mrq)3.81
Total Debt (mrq)21.47M
Total Debt/Equity (mrq)17.47
Current Ratio (mrq)11.10
Book Value Per Share (mrq)3.18

Cash Flow Statement

Operating Cash Flow (ttm)-85.07M
Levered Free Cash Flow (ttm)-49.34M